Skip to main content

Establishing Best Practice Guidelines to Improve the Rigor, Reproducibility, and Transparency of the Maternal Immune Activation (MIA) Animal Model of Neurodevelopmental Abnormalities

Publication ,  Conference
Pletnikov, M; Kentner, A; Meyer, U; Hsiao, E; McAllister, AK; Bauman, M; Bilbo, S; Yolken, R; Brown, A; Pearce, B
Published in: NEUROPSYCHOPHARMACOLOGY
2017

Duke Scholars

Published In

NEUROPSYCHOPHARMACOLOGY

EISSN

1740-634X

ISSN

0893-133X

Publication Date

2017

Volume

42

Start / End Page

S14 / S15

Related Subject Headings

  • Psychiatry
  • 5202 Biological psychology
  • 3209 Neurosciences
  • 17 Psychology and Cognitive Sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pletnikov, M., Kentner, A., Meyer, U., Hsiao, E., McAllister, A. K., Bauman, M., … Pearce, B. (2017). Establishing Best Practice Guidelines to Improve the Rigor, Reproducibility, and Transparency of the Maternal Immune Activation (MIA) Animal Model of Neurodevelopmental Abnormalities. In NEUROPSYCHOPHARMACOLOGY (Vol. 42, pp. S14–S15).
Pletnikov, Mikhail, Amanda Kentner, Urs Meyer, Elaine Hsiao, A Kimberley McAllister, Melissa Bauman, Staci Bilbo, Robert Yolken, Alan Brown, and Brad Pearce. “Establishing Best Practice Guidelines to Improve the Rigor, Reproducibility, and Transparency of the Maternal Immune Activation (MIA) Animal Model of Neurodevelopmental Abnormalities.” In NEUROPSYCHOPHARMACOLOGY, 42:S14–15, 2017.
Pletnikov M, Kentner A, Meyer U, Hsiao E, McAllister AK, Bauman M, et al. Establishing Best Practice Guidelines to Improve the Rigor, Reproducibility, and Transparency of the Maternal Immune Activation (MIA) Animal Model of Neurodevelopmental Abnormalities. In: NEUROPSYCHOPHARMACOLOGY. 2017. p. S14–5.
Pletnikov M, Kentner A, Meyer U, Hsiao E, McAllister AK, Bauman M, Bilbo S, Yolken R, Brown A, Pearce B. Establishing Best Practice Guidelines to Improve the Rigor, Reproducibility, and Transparency of the Maternal Immune Activation (MIA) Animal Model of Neurodevelopmental Abnormalities. NEUROPSYCHOPHARMACOLOGY. 2017. p. S14–S15.

Published In

NEUROPSYCHOPHARMACOLOGY

EISSN

1740-634X

ISSN

0893-133X

Publication Date

2017

Volume

42

Start / End Page

S14 / S15

Related Subject Headings

  • Psychiatry
  • 5202 Biological psychology
  • 3209 Neurosciences
  • 17 Psychology and Cognitive Sciences
  • 11 Medical and Health Sciences